GlassScriptPhysician profile
Myron B Jones
NPI 1225106420
$1,270.82
in general payments reported to CMS, 2019-2025
18 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.58 · 2021: $137 · 2022: $274 · 2023: $333 · 2024: $267 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $835.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $251.55 | 2022-2024 | |
| Acclarent, INC | $193.84 | 2021-2022 | |
| Genzyme Corporation | $147.03 | 2019-2025 | |
| Glaxosmithkline, LLC. | $117.55 | 2024-2025 | Nucala |
| Abbvie INC. | $108.58 | 2023 | |
| Boston Scientific Corporation | $105.52 | 2022 | |
| Aerin Medical INC. | $56.93 | 2023-2024 | |
| Integra Lifesciences Corporation | $55.17 | 2024-2025 | Acclarent Aera, Inspira Air, Relieva Spinplus Nav |
| Stryker Corporation | $30.78 | 2021-2023 | Scopis Ent |
| Axogen | $30.48 | 2025 | |
| Merck Sharp & Dohme LLC | $30.35 | 2023 | |
| Ambu INC. | $24.14 | 2022 | |
| Novo Nordisk INC | $23.16 | 2019-2021 | |
| Polynovo North America LLC | $22.19 | 2024 | Novosorb Btm |
| Regeneron Healthcare Solutions, INC. | $21.99 | 2025 | Dupixent |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $20.61 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Astrazeneca Pharmaceuticals LP | $17.56 | 2025 | Tezspire |
| Inspire Medical Systems, INC. | $13.39 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Myron Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.